News about Global Pharma

Aurobindo Pharma Signs MoU With GITAM

Aurobindo Pharma Limited entered a memorandum of understanding (MoU) with GITAM to train its employees from the Vizag cluster. As a part of the MoU, the institution will offer a custom designed management development programme (MDP) ‘Auro Astra’ to Aurobindo Pharma employees.

Global Pharma | 26/09/2023 | By Manvi |  1095

Quadria Capital-Backed Akums Kicks Off 2024 IPO Plans

Delhi-based Akums Drugs and Pharmaceuticals Ltd has picked four investment banks as advisors and kicked off the process to prepare for a listing in 2024.

Global Pharma | 26/09/2023 | By Manvi |  1498

Mankind Pharma Partners with SpiceJet, Elevating Brand Awareness through Plane Displays

Mankind Pharma has taken a pioneering step by introducing 120 DMF quality API medicines in the Indian market, which conform to stringent international standards.

Global Pharma | 22/09/2023 | By Manvi |  802

Belgium Firm Eurofins Opens Bio-Pharma Services Campus at Genome Valley

Eurofins, has opened its bio-pharma services campus comprising about one lakh sq ft of laboratory and office space on 15 acres at Genome Valley in Hyderabad.

Global Pharma | 22/09/2023 | By Manvi |  1058

Venus Remedies Extends its Oncology Portfolio in South Eastern Europe

Oncology drugs constitute the largest proportion of the Serbian pharmaceutical market (projected to reach USD 397.40m in 2023), where Venus Remedies has secured five marketing approvals, all in the oncology space.

Global Pharma | 22/09/2023 | By Manvi |  701

Alkem Laboratories Ltd Brands API Business as Alkem Activa

This strategic move underscores the company’s commitment to becoming a formidable global player in the API sector.

Global Pharma | 22/09/2023 | By Manvi |  1384

SOMAI Pharmaceuticals Receive EU-GMP Certification

SOMAÍ Pharmaceuticals announces that it has received authorisation for its facility located in Lisbon, Portugal from the Portuguese Health Authority INFRAMED.

Global Pharma | 22/09/2023 | By Manvi |  744

CordenPharma Inaugurates Increased Peptide Production of the Largest Worldwide SPPS Manufacturing Plant

CordenPharma announces the inauguration of increased commercial peptide production capacity with newly-upgraded facilities at CordenPharma Colorado, the largest Solid-Phase Peptide Synthesis (SPPS) Manufacturing facility worldwide.

Global Pharma | 22/09/2023 | By Manvi |  571

Pharmanovia Acquires Global Central Nervous System (CNS) Portfolio From Sanofi

The brands span four therapy areas of ongoing unmet need associated with CNS disorders - psycholeptic, anxiolytic, anti-epileptic and anti-psychotic.

Global Pharma | 19/09/2023 | By Manvi |  897

Torrent Pharma in Talks with CVC, Bain Capital for Cipla Bid

Torrent Pharmaceuticals is in talks with private equity funds CVC Capital Partners and Bain Capital to raise up to $1.5 billion to bid for India's Cipla, according to three sources with direct knowledge of the matter.<br />

Global Pharma | 19/09/2023 | By Manvi |  546